Research & Literature

Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry.

Roston TM, Vinocur JM, Maginot KR, et al.

Circulation. Arrhythmia and electrophysiology 2015; (8(3)):633-42 doi:10.1161/CIRCEP.114.002217.

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, et al.

Genetics in medicine : official journal of the American College of Medical Genetics 2015; (17(5)):405-24 doi:10.1038/gim.2015.30.

Clinical and molecular characterization of a cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia.

Wangüemert F, Bosch Calero C, Pérez C, et al.

Heart rhythm 2015; (12(7)):1636-43.

Noninvasive Multimodality Imaging in ARVD/C.

Te Riele ASJM, Tandri H, Sanborn DM, Bluemke DA

JACC. Cardiovascular imaging 2015; (8(5)):597-611 doi:10.1016/j.jcmg.2015.02.007.

Arrhythmogenic right ventricular cardiomyopathy. Contribution of cardiac magnetic resonance imaging to the diagnosis.

Perazzolo Marra M, Rizzo S, Bauce B, et al.

Herz 2015; (40(4)):600-6 doi:10.1007/s00059-015-4228-0.

Pathogenesis of Arrhythmogenic Cardiomyopathy.

Asimaki A, Kleber AG, Saffitz JE

The Canadian journal of cardiology 2015; (31(11)):1313-24.

Physical and Psychological Consequences of Left Cardiac Sympathetic Denervation in Long-QT Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia.

Waddell-Smith KE, Ertresvaag KN, Li J, et al.

Circulation. Arrhythmia and electrophysiology 2015; (8(5)):1151-8 doi:10.1161/CIRCEP.115.003159.

Nadolol decreases the incidence and severity of ventricular arrhythmias during exercise stress testing compared with β1-selective β-blockers in patients with catecholaminergic polymorphic ventricular tachycardia.

Leren IS, Saberniak J, Majid E, et al.

Heart rhythm 2016; (13(2)):433-40.

Arrhythmogenic right ventricular cardiomyopathy, clinical manifestations, and diagnosis.

Haugaa KH, Haland TF, Leren IS, et al.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2016; (18(7)):965-72 doi:10.1093/europace/euv340.

Patient Outcomes From a Specialized Inherited Arrhythmia Clinic.

Adler A, Sadek MM, Chan AY, et al.

Circulation. Arrhythmia and electrophysiology 2016; (9(1)):e003440.

Comparison of patients with early-phase arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract ventricular tachycardia.

Saberniak J, Leren IS, Haland TF, et al.

European heart journal. Cardiovascular Imaging 2017; (18(1)):62-69 doi:10.1093/ehjci/jew014.

Exercise and Inherited Arrhythmias.

Cheung CC, Laksman ZW, Mellor G, et al.

The Canadian journal of cardiology 2016; (32(4)):452-8.

Interdisciplinary psychosocial care for families with inherited cardiovascular diseases.

Caleshu C, Kasparian NA, Edwards KS, et al.

Trends in cardiovascular medicine 2016; (26(7)):647-53.

Clinical and genetic profile of catecholaminergic polymorphic ventricular tachycardia in Hong Kong Chinese children.

Yu TC, Liu AP, Lun KS, et al.

Hong Kong medical journal = Xianggang yi xue za zhi 2016; (22(4)):314-9 doi:10.12809/hkmj154653.

Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Associated With Ryanodine Receptor (RyR2) Gene Mutations　- Long-Term Prognosis After Initiation of Medical Treatment.

Kawata H, Ohno S, Aiba T, et al.

Circulation journal : official journal of the Japanese Circulation Society 2016; (80(9)):1907-15 doi:10.1253/circj.CJ-16-0250.

Cardiac Abnormalities in First-Degree Relatives of Unexplained Cardiac Arrest Victims: A Report From the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry.

Steinberg C, Padfield GJ, Champagne J, et al.

Circulation. Arrhythmia and electrophysiology 2016; (9(9)).

Extensive Ca2+ leak through K4750Q cardiac ryanodine receptors caused by cytosolic and luminal Ca2+ hypersensitivity.

Uehara A, Murayama T, Yasukochi M, et al.

The Journal of general physiology 2017; (149(2)):199-218 doi:10.1085/jgp.201611624.

Avoiding sports-related sudden cardiac death in children with congenital channelopathy : Recommendations for sports activities.

Lang CN, Steinfurt J, Odening KE

Herz 2017; (42(2)):162-170 doi:10.1007/s00059-017-4549-2.

Efficacy of Flecainide in the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia: A Randomized Clinical Trial.

Kannankeril PJ, Moore JP, Cerrone M, et al.

JAMA cardiology 2017; (2(7)):759-766 doi:10.1001/jamacardio.2017.1320.

Idiopathic Polymorphic Ventricular Tachycardia: a "Benign Disease" with a Touch of Bad Luck?

Viskin S

Korean circulation journal 2017; (47(3)):299-306 doi:10.4070/kcj.2016.0303.

The genetics underlying idiopathic ventricular fibrillation: A special role for catecholaminergic polymorphic ventricular tachycardia?

Leinonen JT, Crotti L, Djupsjöbacka A, et al.

International journal of cardiology 2018; (250()):139-145 doi:10.1016/j.ijcard.2017.10.016.

Seizure Triggered by Sick Sinus Syndrome.

Patel N, Majeed F, Sule AA

BMJ case reports 2017; (2017()) doi:10.1136/bcr-2017-222011.

Ion Channel Disorders and Sudden Cardiac Death.

Garcia-Elias A, Benito B

International journal of molecular sciences 2018; (19(3)) doi:10.3390/ijms19030692.

Differentiating motor phenomena in tilt-induced syncope and convulsive seizures.

Shmuely S, Bauer PR, van Zwet EW, et al.

Neurology 2018; (90(15)):e1339-e1346 doi:10.1212/WNL.0000000000005301.

A delayed diagnosis of catecholaminergic polymorphic ventricular tachycardia with a mutant of RYR2 at c.7580T>G for 6 years in a 9-year-old child.

Duan H, Lu Y, Yan S, et al.

Medicine 2018; (97(16)):e0368 doi:10.1097/MD.0000000000010368.

Impact of Exercise Restriction on Arrhythmic Risk Among Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.

Wang W, Orgeron G, Tichnell C, et al.

Journal of the American Heart Association 2018; (7(12)) doi:10.1161/JAHA.118.008843.

Genetics of and pathogenic mechanisms in arrhythmogenic right ventricular cardiomyopathy.

Vimalanathan AK, Ehler E, Gehmlich K

Biophysical reviews 2018; (10(4)):973-982 doi:10.1007/s12551-018-0437-0.

Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: A systematic review.

Roston TM, Jones K, Hawkins NM, et al.

Heart rhythm 2018; (15(12)):1791-1799 doi:10.1016/j.hrthm.2018.06.046.

Impact of dynamic physical exercise on high-risk definite arrhythmogenic right ventricular cardiomyopathy.

Ruiz Salas A, Barrera Cordero A, Navarro-Arce I, et al.

Journal of cardiovascular electrophysiology 2018; (29(11)):1523-1529 doi:10.1111/jce.13704.

Catecholaminergic polymorphic ventricular tachycardia managed as orthostatic dysregulation and epilepsy in 11- and 15-year-old sisters.

Fujita S, Nishida K, Irabu H, et al.

Pediatrics international : official journal of the Japan Pediatric Society 2018; (60(11)):998-1001 doi:10.1111/ped.13688.

Exercise testing oversights underlie missed and delayed diagnosis of catecholaminergic polymorphic ventricular tachycardia in young sudden cardiac arrest survivors.

Giudicessi JR, Ackerman MJ

Heart rhythm 2019; (16(8)):1232-1239 doi:10.1016/j.hrthm.2019.02.012.

A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.

Cadrin-Tourigny J, Bosman LP, Nozza A, et al.

European heart journal 2019; (40(23)):1850-1858 doi:10.1093/eurheartj/ehz103.

Catecholaminergic Polymorphic Ventricular Tachycardia: An Unusual Case of Fright-Induced Prehospital Cardiac Arrest in a Healthy 6-Year-Old Child.

Wilson M, Schwartz S, Verbeek PR

Prehospital emergency care 2020; (24(1)):94-99 doi:10.1080/10903127.2019.1612972.

Clinical features and arrhythmic complications of patients with pediatric-onset arrhythmogenic right ventricular dysplasia.

Sevinç Şengül F, Tunca Şahin G, Özgür S, et al.

Anatolian journal of cardiology 2019; (22(2)):60-67 doi:10.14744/AnatolJCardiol.2019.56985.

CPVT: Arrhythmogenesis, Therapeutic Management, and Future Perspectives. A Brief Review of the Literature.

Baltogiannis GG, Lysitsas DN, di Giovanni G, et al.

Frontiers in cardiovascular medicine 2019; (6()):92 doi:10.3389/fcvm.2019.00092.

Risk stratification for ventricular arrhythmias and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy: an update.

Cadrin-Tourigny J, Bosman LP, Tadros R, et al.

Expert review of cardiovascular therapy 2019; (17(9)):645-651 doi:10.1080/14779072.2019.1657831.

BASIC AND CLINICAL INSIGHTS IN CATECHOLAMINERGIC (FAMILIAL) POLYMORPHIC VENTRICULAR TACHYCARDIA.

Márquez MF, Totomoch-Serra A, Rueda A, et al.

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 2019; (71(4)):226-236 doi:10.24875/RIC.19002939.

Psychological Issues in Managing Families with Inherited Cardiovascular Diseases.

Ingles J

Cold Spring Harbor perspectives in medicine 2020; (10(9)) doi:10.1101/cshperspect.a036558.

Genetic Testing in Inherited Heart Diseases.

Ingles J, Macciocca I, Morales A, Thomson K

Heart, lung & circulation 2020; (29(4)):505-511 doi:10.1016/j.hlc.2019.10.014.

50 Years of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) - Time to Explore the Dark Side of the Moon.

Pflaumer A, Wilde AAM, Charafeddine F, Davis AM

Heart, lung & circulation 2020; (29(4)):520-528 doi:10.1016/j.hlc.2019.10.013.

Catecholaminergic Polymorphic Ventricular Tachycardia.

Kim CW, Aronow WS, Dutta T, et al.

Cardiology in review 2020; (28(6)):325-331 doi:10.1097/CRD.0000000000000302.

The Brain-Heart Connection in Sympathetically Triggered Inherited Arrhythmia Syndromes.

Winbo A, Paterson DJ

Heart, lung & circulation 2020; (29(4)):529-537 doi:10.1016/j.hlc.2019.11.002.

Cardiac arrest in a mother and daughter and the identification of a novel RYR2 variant, predisposing to low penetrant catecholaminergic polymorphic ventricular tachycardia in a four-generation Canadian family.

Tung M, Van Petegem F, Lauson S, et al.

Molecular genetics & genomic medicine 2020; (8(4)):e1151 doi:10.1002/mgg3.1151.

Catheter and Device Management of Inherited Cardiac Conditions.

Bennett R, Campbell T, Kumar S

Heart, lung & circulation 2020; (29(4)):594-606 doi:10.1016/j.hlc.2019.12.009.

Prognostic impact of misdiagnosis of cardiac channelopathies as epilepsy.

Ramos-Maqueda J, Bermúdez-Jiménez F, Ruiz RM, et al.

PloS one 2020; (15(4)):e0231442 doi:10.1371/journal.pone.0231442.

A Population-Based Registry of Patients With Inherited Cardiac Conditions and Resuscitated Cardiac Arrest.

Rucinski C, Winbo A, Marcondes L, et al.

Journal of the American College of Cardiology 2020; (75(21)):2698-2707 doi:10.1016/j.jacc.2020.04.004.

Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria.

Corrado D, Perazzolo Marra M, Zorzi A, et al.

International journal of cardiology 2020; (319()):106-114 doi:10.1016/j.ijcard.2020.06.005.

Exercise restriction is protective for genotype-positive family members of arrhythmogenic right ventricular cardiomyopathy patients.

Wang W, Tichnell C, Murray BA, et al.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2020; (22(8)):1270-1278 doi:10.1093/europace/euaa105.

Arrhythmogenic cardiomyopathy: An in-depth look at molecular mechanisms and clinical correlates.

Costa S, Cerrone M, Saguner AM, et al.

Trends in cardiovascular medicine 2021; (31(7)):395-402 doi:10.1016/j.tcm.2020.07.006.

Management of ventricular electrical storm: a contemporary appraisal.

Kowlgi GN, Cha YM

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2020; (22(12)):1768-1780 doi:10.1093/europace/euaa232.

Diagnostic electrophysiological study in a highly trained young woman with presyncopal symptoms during exercise: a case report.

de la Guía-Galipienso F, Sanchis-Gomar F, Quesada-Dorador A

Annals of translational medicine 2021; (9(2)):177 doi:10.21037/atm-20-3492.

International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework.

James CA, Jongbloed JDH, Hershberger RE, et al.

Circulation. Genomic and precision medicine 2021; (14(3)):e003273 doi:10.1161/CIRCGEN.120.003273.

A Visual Resolution of Cardiotoxicity: A Case Report of Digoxin-Induced Bidirectional Ventricular Tachycardia.

Phyu Phyu Aung T, Buddhavarapu S, Park WJ, et al.

Cureus 2021; (13(5)):e15134 doi:10.7759/cureus.15134.

Multiphoton Imaging of Ca2+ Instability in Acute Myocardial Slices from a RyR2R2474S Murine Model of Catecholaminergic Polymorphic Ventricular Tachycardia.

Borile G, Zaglia T, E Lehnart S, Mongillo M

Journal of clinical medicine 2021; (10(13)) doi:10.3390/jcm10132821.

Complications of implantable cardioverter-defibrillator treatment in arrhythmogenic right ventricular cardiomyopathy.

Christensen AH, Platonov PG, Svensson A, et al.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2022; (24(2)):306-312 doi:10.1093/europace/euab112.

Two Novel Variants in Genes of Arrhythmogenic Right Ventricular Cardiomyopathy - a Case Report.

Gabartaitė D, Jančauskaitė D, Mikštienė V, et al.

Acta medica Lituanic 2021; (28(1)):127-135 doi:10.15388/Amed.2020.28.1.1.

Pediatric Catecholaminergic Polymorphic Ventricular Tachycardia: A Translational Perspective for the Clinician-Scientist.

Kallas D, Lamba A, Roston TM, et al.

International journal of molecular sciences 2021; (22(17)) doi:10.3390/ijms22179293.

Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy.

Corrado D, Zorzi A, Cipriani A, et al.

Journal of the American Heart Association 2021; (10(18)):e021987 doi:10.1161/JAHA.121.021987.

Physical activity and aerobic fitness in children with inherited cardiac diseases.

Boisson A, De La Villeon G, Huguet H, et al.

Archives of cardiovascular diseases 2021; (114(11)):727-736 doi:10.1016/j.acvd.2021.07.004.

Arrhythmogenic right ventricular cardiomyopathy in the pediatric population.

Cohen MI, Atkins MB

Current opinion in cardiology 2022; (37(1)):99-108 doi:10.1097/HCO.0000000000000937.

An International Multicenter Cohort Study on β-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular Tachycardia.

Peltenburg PJ, Kallas D, Bos JM, et al.

Circulation 2022; (145(5)):333-344 doi:10.1161/CIRCULATIONAHA.121.056018.

Arrhythmogenic Right Ventricular Cardiomyopathy in Pediatric Patients: An Important but Underrecognized Clinical Entity.

Te Riele ASJM, James CA, Calkins H, Tsatsopoulou A

Frontiers in pediatrics 2021; (9()):750916 doi:10.3389/fped.2021.750916.

Variant interpretation in molecular autopsy: a useful dilemma.

Scheiper-Welling S, Tabunscik M, Gross TE, et al.

International journal of legal medicine 2022; (136(2)):475-482 doi:10.1007/s00414-021-02764-z.

Multimodality Imaging in Arrhythmogenic Right Ventricular Cardiomyopathy.

Malik N, Mukherjee M, Wu KC, et al.

Circulation. Cardiovascular imaging 2022; (15(2)):e013725 doi:10.1161/CIRCIMAGING.121.013725.

Diagnostic Challenges in Rare Causes of Arrhythmogenic Cardiomyopathy-The Role of Cardiac MRI.

Manole S, Pintican R, Popa G, et al.

Journal of personalized medicine 2022; (12(2)) doi:10.3390/jpm12020187.

Clinical Characteristics and Follow-Up of Pediatric-Onset Arrhythmogenic Right Ventricular Cardiomyopathy.

Roudijk RW, Verheul L, Bosman LP, et al.

JACC. Clinical electrophysiology 2022; (8(3)):306-318 doi:10.1016/j.jacep.2021.09.001.

Identification of two variants in AGRN and RPL3L genes in a patient with catecholaminergic polymorphic ventricular tachycardia suggesting new candidate disease genes and digenic inheritance.

Jaouadi H, Chabrak S, Lahbib S, et al.

Clinical case reports 2022; (10(2)):e05339 doi:10.1002/ccr3.5339.

Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers.

Mazzanti A, Kukavica D, Trancuccio A, et al.

JAMA cardiology 2022; (7(5)):504-512 doi:10.1001/jamacardio.2022.0219.

Sarcoplasmic Reticulum Ca2+ Dysregulation in the Pathophysiology of Inherited Arrhythmia: An Update.

Du Y, Demillard LJ, Ren J

Biochemical pharmacology 2022; (200()):115059 doi:10.1016/j.bcp.2022.115059.

A Rare Presentation of Sick Sinus Syndrome: Generalized Seizures.

Elkattawy S, Younes I, Alyacoub R, et al.

Cureus 2022; (14(3)):e23631 doi:10.7759/cureus.23631.

Latent Causes of Sudden Cardiac Arrest.

Krahn AD, Tfelt-Hansen J, Tadros R, et al.

JACC. Clinical electrophysiology 2022; (8(6)):806-821 doi:10.1016/j.jacep.2021.12.014.

Structural analyses of human ryanodine receptor type 2 channels reveal the mechanisms for sudden cardiac death and treatment.

Miotto MC, Weninger G, Dridi H, et al.

Science advances 2022; (8(29)):eabo1272 doi:10.1126/sciadv.abo1272.

Cardiogenetics: the role of genetic testing for inherited arrhythmia syndromes and sudden death.

Specterman MJ, Behr ER

Heart (British Cardiac Society) 2023; (109(6)):434-441 doi:10.1136/heartjnl-2021-320015.

Biventricular Arrhythmogenic Cardiomyopathy Associated with a Novel Heterozygous Plakophilin-2 Early Truncating Variant.

Çimen T, Wilzeck VC, Montrasio G, et al.

Journal of clinical medicine 2022; (11(24)) doi:10.3390/jcm11247513.

The safety of sports in children with inherited arrhythmia substrates.

Katyal A, Li COY, Franciosi S, Sanatani S

Frontiers in pediatrics 2023; (11()):1151286 doi:10.3389/fped.2023.1151286.

Management of Inherited Arrhythmia Syndromes: A HiRO Consensus Handbook on Process of Care.

Janzen ML, Davies B, Laksman ZWM, et al.

CJC open 2023; (5(4)):268-284 doi:10.1016/j.cjco.2023.02.006.

Catecholaminergic Polymorphic Ventricular Tachycardia: A Review of Therapeutic Strategies.

Bergeman AT, Wilde AAM, van der Werf C

Cardiac electrophysiology clinics 2023; (15(3)):293-305 doi:10.1016/j.ccep.2023.04.002.

Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report.

Corrado D, Anastasakis A, Basso C, et al.

International journal of cardiology 2024; (395()):131447 doi:10.1016/j.ijcard.2023.131447.

Identification of concealed cardiomyopathy using next-generation sequencing-based genetic testing in Korean patients initially diagnosed with idiopathic ventricular fibrillation.

Jeong JH, Kim YG, Oh SK, et al.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2023; (25(11)) doi:10.1093/europace/euad313.

Sudden Cardiac Arrest in the Paediatric Population.

Franciosi S, Abrams DJ, Ingles J, Sanatani S

CJC pediatric and congenital heart disease 2022; (1(2)):45-59 doi:10.1016/j.cjcpc.2022.02.001.

Right ventricular assessment of the adolescent footballer's heart.

Augustine DX, Willis J, Sivalokanathan S, et al.

Echo research and practice 2024; (11(1)):7 doi:10.1186/s44156-023-00039-4.

Diagnostic yield from cardiac gene testing for inherited cardiac conditions and re-evaluation of pre-ACMG variants of uncertain significance.

Murphy J, Kirk CW, Lambert DM, et al.

Irish journal of medical science 2024; (193(4)):1775-1785 doi:10.1007/s11845-024-03650-4.

Imaging Features of Arrhythmogenic Cardiomyopathies.

Galizia MS, Attili AK, Truesdell WR, et al.

Radiographics : a review publication of the Radiological Society of North America, Inc 2024; (44(4)):e230154 doi:10.1148/rg.230154.

Catecholaminergic Polymorphic Ventricular Tachycardia: Clinical Characteristics, Diagnostic Evaluation and Therapeutic Strategies.

Aggarwal A, Stolear A, Alam MM, et al.

Journal of clinical medicine 2024; (13(6)) doi:10.3390/jcm13061781.

Management of patients with an electrical storm or clustered ventricular arrhythmias: a clinical consensus statement of the European Heart Rhythm Association of the ESC-endorsed by the Asia-Pacific Heart Rhythm Society, Heart Rhythm Society, and Latin-American Heart Rhythm Society.

Lenarczyk R, Zeppenfeld K, Tfelt-Hansen J, et al.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2024; (26(4)) doi:10.1093/europace/euae049.

An international multicenter cohort study on implantable cardioverter-defibrillators for the treatment of symptomatic children with catecholaminergic polymorphic ventricular tachycardia.

Lamba A, Roston TM, Peltenburg PJ, et al.

Heart rhythm 2024; (21(10)):1767-1776 doi:10.1016/j.hrthm.2024.04.006.

Prognosis and clinical management of asymptomatic family members with RYR2-mediated catecholaminergic polymorphic ventricular tachycardia: a review.

Peltenburg PJ, Gibson H, Wilde AAM, et al.

Cardiology in the young 2024; (34(6)):1182-1189 doi:10.1017/S1047951124000714.

Contemporary diagnostic approach to arrhythmogenic cardiomyopathy: The three-step work-up.

Graziano F, Zorzi A, Cipriani A, et al.

Trends in cardiovascular medicine 2025; (35(2)):107-113 doi:10.1016/j.tcm.2024.09.002.

Implantable Cardioverter Defibrillator for Primary Prevention in Children With Arrhythmogenic Right Ventricular Cardiomyopathy: A Case Series.

Nagashima-Otsuki A, Ishii T, Yamaguchi Y, et al.

Cureus 2025; (17(1)):e77253 doi:10.7759/cureus.77253.

Cardiac Channelopathies: Clinical Diagnosis and Promising Therapeutics.

Dib Nehme R, Sinno L, Shouman W, et al.

Journal of the American Heart Association 2025; (14(9)):e040072 doi:10.1161/JAHA.124.040072.

Variant sub-tiering, disease-gene associations and strictness of clinical criteria improves the interpretation of variants of uncertain significance in hereditary cardiomyopathies and rhythm disorders.

Castori M, Mastroianno S, Fontana A, et al.

Journal of human genetics 2025; (70(7)):349-358 doi:10.1038/s10038-025-01344-y.

Sports or no sports? How to manage the young arrhythmia patient.

Ertugrul I, Blom NA,

Herzschrittmachertherapie & Elektrophysiologie 2025; (36(3)):211-218 doi:10.1007/s00399-025-01089-3.

Psychosocial impact of inherited arrhythmia syndromes on anxiety in paediatric patients and their families.

Babayeva S, Akgül S, Karagöz T, Ertuğrul İ

Cardiology in the young 2025; (35(8)):1683-1689 doi:10.1017/S1047951125101236.

Management of channelopathies in children.

Krause U

Herzschrittmachertherapie & Elektrophysiologie 2025; (36(3)):186-191 doi:10.1007/s00399-025-01098-2.

The blueprint of neurocardiac crosstalk in arrhythmic syndromes.

Zaglia T, Perumal Vanaja I, Guazzo A, Mongillo M

American journal of physiology. Cell physiology 2025; (329(4)):C1038-C1045 doi:10.1152/ajpcell.00558.2025.

Outcomes of Ventricular Tachycardia Catheter Ablation in Pediatric Arrhythmogenic Right Ventricular Cardiomyopathy.

Alahwany SH, Uetake S, Jiménez-Jáimez J, et al.

Circulation. Arrhythmia and electrophysiology 2025; (18(11)):e014075 doi:10.1161/CIRCEP.125.014075.

MaveMD: A functional data resource for genomic medicine.

McEwen AE, Stone J, Tejura M, et al.

medRxiv : the preprint server for health sciences 2025; doi:10.1101/2025.11.15.25336228.

Paediatric inherited arrhythmia clinic: developing a new model of care.

Robinson KM, Asakai H, Turner C, et al.

BMJ paediatrics open 2026; (10(1)) doi:10.1136/bmjpo-2025-004403.

Structural and Functional Regulation of RyR2 in Cardiac Calcium Handling and Arrhythmogenesis.

Gao K, Wang W, Ling Y, et al.

Biomedicines 2026; (14(3)) doi:10.3390/biomedicines14030662.

Unexpected Pediatric Cardiac Arrest in a Toddler: A Case of Catecholaminergic Polymorphic Ventricular Tachycardia Presenting as Ventricular Fibrillation.

Disla Cuevas A, Tran C, Daya M, Chung S

Pediatric emergency care 2026; (42(9)):e128-e133 doi:10.1097/PEC.0000000000003603.

How Many CPVT Patients Need an ICD?: The Impact of Left Cardiac Sympathetic Denervation.

Bos JM, Dusi V, Viskin D, et al.

JACC. Clinical electrophysiology 2026; (12(9)):2182-2194 doi:10.1016/j.jacep.2026.03.027.

Catecholaminergic Polymorphic Ventricular Tachycardia Type 2 Presenting as Seizure in a Child: Diagnostic Pitfalls.

Rahimpour F, Moghaddam ES, Fallahi NA

JACC. Case reports 2026; (31(36)):109233 doi:10.1016/j.jaccas.2026.109233.

Charged to death: Energy drinks, smart drugs, and sudden cardiac death.

Sessa F, Ministeri F, Chisari M, et al.

Experimental and molecular pathology 2026; (147()):105068 doi:10.1016/j.yexmp.2026.105068.

Diagnosis and management of very rare primary arrhythmia syndromes in children and adults: a Clinical Consensus Statement of the European Heart Rhythm Association of the ESC and the Association of Cardiovascular Nursing & Allied Professions of the ESC, endorsed by the Association for European Paediatric and Congenital Cardiology.

Sarquella-Brugada G, Mazzanti A, Baban A, et al.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2026; (28(8)) doi:10.1093/europace/euag184.